CD4 and benign prostatic hyperplasia: Furthermore, there was a substantially increased presence of potential regulatory T cells (CD4+/CD25highCD127−/low) in BPH tissue as compared to PBMCs (median 16.6% vs. 7.2%, p<0.0001) (Table 2).